111 related articles for article (PubMed ID: 9398081)
1. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
[TBL] [Abstract][Full Text] [Related]
2. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH3T3 cells.
Ghosh PM; Moyer ML; Mott GE; Kreisberg JI
J Cell Biochem; 1999 Sep; 74(4):532-43. PubMed ID: 10440923
[TBL] [Abstract][Full Text] [Related]
6. Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells.
Ownby SE; Hohl RJ
Lipids; 2002 Feb; 37(2):185-92. PubMed ID: 11908910
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of simvastatin on mesangial cells.
Heusinger-Ribeiro J; Fischer B; Goppelt-Struebe M
Kidney Int; 2004 Jul; 66(1):187-95. PubMed ID: 15200425
[TBL] [Abstract][Full Text] [Related]
9. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
10. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells.
Miquel K; Pradines A; Tercé F; Selmi S; Favre G
J Biol Chem; 1998 Oct; 273(40):26179-86. PubMed ID: 9748300
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin induces apoptosis in malignant mesothelioma cells.
Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
[TBL] [Abstract][Full Text] [Related]
13. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.
Shipman CM; Croucher PI; Russell RG; Helfrich MH; Rogers MJ
Cancer Res; 1998 Dec; 58(23):5294-7. PubMed ID: 9850051
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
[TBL] [Abstract][Full Text] [Related]
16. Role of inhibitors of isoprenylation in proliferation, phenotype and apoptosis of human retinal pigment epithelium.
Capeáns C; Piñeiro A; Pardo M; Carneiro C; Blanco MJ; Viñuela JM; Sánchez Salorio M; Domínguez F
Graefes Arch Clin Exp Ophthalmol; 2001 Mar; 239(3):188-98. PubMed ID: 11405068
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
Fernández-Hernando C; Suárez Y; Lasunción MA
Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
[TBL] [Abstract][Full Text] [Related]
18. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells.
Crick DC; Waechter CJ; Andres DA
SAAS Bull Biochem Biotechnol; 1996; 9():37-42. PubMed ID: 8652130
[TBL] [Abstract][Full Text] [Related]
19. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
